相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JCV serology in time: 3years of follow-up
M. Cambron et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Measurement of the W boson polarisation in t(t)over-barevents from pp collisions at √s=8 TeV in the lepton plus jets channel with ATLAS
M. Aaboud et al.
EUROPEAN PHYSICAL JOURNAL C (2017)
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?
S. Mornese Pinna et al.
JOURNAL OF NEUROVIROLOGY (2017)
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - YES
Siew Mei Yap et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA
Joseph R. Berger et al.
JAMA NEUROLOGY (2017)
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - YES
Siew Mei Yap et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Progressive Multifocal Leukoencephalopathy: Endemic Viruses and Lethal Brain Disease
Sheila A. Haley et al.
Annual Review of Virology (2017)
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS
Mike P. Wattjes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
PML risk stratification using anti-JCV antibody index and L-selectin
Nicholas Schwab et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients
Linda A. Lieberman et al.
NEUROLOGY (2016)
PML risk stratification using anti-JCV antibody index and L-selectin
Nicholas Schwab et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
High cumulative JC virus seroconversion rate during long-term use of natalizumab
A. Vennegoor et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
Milton H. Werner et al.
JOURNAL OF NEUROVIROLOGY (2016)
Reassessing the risk of natalizumab-associated PML
Joseph R. Berger et al.
JOURNAL OF NEUROVIROLOGY (2016)
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Mike P. Wattjes et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Mike P. Wattjes et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
Julian Borchardt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
Nicholas Schwab et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
J. Hodel et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Lipid-Specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy during Treatment with Natalizumab
Luisa M. Villar et al.
ANNALS OF NEUROLOGY (2015)
Infection Risk in Patients on Multiple Sclerosis Therapeutics
Eric M. Williamson et al.
CNS DRUGS (2015)
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report
Serena Delbue et al.
INTERVIROLOGY (2015)
Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine
Tuuli Pietila et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis
F. Asztely et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
Dejan Pavlovic et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection
Melissa S. Maginnis et al.
JOURNAL OF NEUROVIROLOGY (2015)
Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
Immune surveillance and response to JC virus infection and PML
Sarah Beltrami et al.
JOURNAL OF NEUROVIROLOGY (2014)
Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy
Mai Miyagawa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Maraviroc and JC Virus-Associated Immune Reconstitution Inflammatory Syndrome
Paul S. Giacomini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Bacterial Pneumonia on Lung Simian Immunodeficiency Virus (SIV) Replication in Alcohol Consuming SIV-Infected Rhesus Macaques
Steve Nelson et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
JC Virus Antibody Status Underestimates Infection Rates
Joseph R. Berger et al.
ANNALS OF NEUROLOGY (2013)
JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
Roberta Antonia Diotti et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants
Caroline F. Ryschkewitsch et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro
Souichi Nukuzuma et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
Maria Inmaculada Dominguez-Mozo et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
David B. Clifford et al.
JOURNAL OF NEUROVIROLOGY (2013)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
Detection of JC Virus-Specific Immune Responses in a Novel Humanized Mouse Model
Chen Sabrina Tan et al.
PLOS ONE (2013)
AIDS-related progressive multifocal leukoencephalopathy (PML): A retrospective study from Pretoria, South Africa
C-M Schutte et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2013)
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
Tarek A. Yousry et al.
ANNALS OF NEUROLOGY (2012)
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain
Michael W. Ferenczy et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis
M. A. Sahraian et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
A. Laroni et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Disease-modifying drugs for multiple sclerosis and JC virus expression
Craig S. Miller et al.
JOURNAL OF NEUROVIROLOGY (2012)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A. K. Trampe et al.
NEUROLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant
Xin Dang et al.
PLOS ONE (2012)
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry
Christian D. S. Nelson et al.
VIROLOGY (2012)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient
A. Balduzzi et al.
BONE MARROW TRANSPLANTATION (2011)
Pathogenesis of Progressive Multifocal Leukoencephalopathy-Revisited
Martyn K. White et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Immune reconstitution inflammatory syndrome in natalizumab-associated PML
I. L. Tan et al.
NEUROLOGY (2011)
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
P. Vermersch et al.
NEUROLOGY (2011)
JC Virus Infection of the Brain
A. K. Bag et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
Richard A. Rudick et al.
ANNALS OF NEUROLOGY (2010)
Neurological complications of immune reconstitution in HIV-infected populations
Tory Johnson et al.
YEAR IN NEUROLOGY 2 (2010)
Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
Joseph R. Berger
DRUG SAFETY (2010)
JC virus-induced progressive multifocal leukoencephalopathy
A. Sami Saribas et al.
FUTURE VIROLOGY (2010)
Human Polyomavirus JC (JCV) Infection of Human B Lymphocytes: A Possible Mechanism for JCV Transmigration across the Blood-Brain Barrier
Moti L. Chapagain et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Detection of Viral DNA Sequences in the Cerebrospinal Fluid of Patients With Multiple Sclerosis
Roberta Mancuso et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Characterization of JC Human Polyomavirus Infection in a Portuguese Population
Ana Matos et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy
Leslie J. Marshall et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy
Chen S. Tan et al.
JOURNAL OF VIROLOGY (2010)
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
Fulminant JC Virus Encephalopathy with Productive Infection of Cortical Pyramidal Neurons
Christian Wuethrich et al.
ANNALS OF NEUROLOGY (2009)
Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro
Margot Brickelmaier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mirtazapine Use in Human Immunodeficiency Virus-Infected Patients With Progressive Multifocal Leukoencephalopathy
Deanna Cettomai et al.
ARCHIVES OF NEUROLOGY (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states
Jelle L. Epker et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating
Kenneth R. Carson et al.
LEUKEMIA & LYMPHOMA (2009)
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
E. Iacobaeus et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Steroids for PML-IRIS A double-edged sword?
Joseph R. Berger
NEUROLOGY (2009)
PML-IRIS in patients with HIV infection Clinical manifestations and treatment with steroids
K. Tan et al.
NEUROLOGY (2009)
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
B. O. Khatri et al.
NEUROLOGY (2009)
Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML)
Shamil R. Sunyaev et al.
PLOS GENETICS (2009)
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis
Andrea De Luca et al.
AIDS (2008)
Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells
Moti L. Chapagain et al.
JOURNAL OF NEUROVIROLOGY (2008)
Pharmacological cdk inhibitor R-Roscovitine suppresses JC virus proliferation
Yasuko Orba et al.
VIROLOGY (2008)
Progressive multifocal leukoencephalopathy in a non-AIDS patient:: high efficiency of combined cytarabine and cidofovir
B. Terrier et al.
REVUE DE MEDECINE INTERNE (2007)
JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event
Roberto Alvarez-Lafuente et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy
Christoph Poehlmann et al.
INTERVIROLOGY (2007)
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis
S. Vulliemoz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene
Xin Dang et al.
JOURNAL OF GENERAL VIROLOGY (2006)
JC virus chromogenic in situ hybridization in brain biopsies from patients with and without PML
Gary W. Procop et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR
AL McNees et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy
A Vendrely et al.
ACTA NEUROPATHOLOGICA (2005)
JC virus granule cell neuronopathy:: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy
IJ Koralnik et al.
ANNALS OF NEUROLOGY (2005)
The atypical antipsychotic agents zisprasidone, risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephatopathy
EL Altschuler et al.
MEDICAL HYPOTHESES (2005)
Meningoencephalitis and demyelination are pathologic manifestations of primary polyomavirus infection in immunosuppressed rhesus monkeys
MK Axthelm et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
The human polyomavirus, JCV, uses serotonin receptors to infect cells
GF Elphick et al.
SCIENCE (2004)
Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects
V Pietropaolo et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2003)
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Seroepidemiology of the human polyomaviruses
A Stolt et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy
W Royal et al.
JOURNAL OF NEUROVIROLOGY (2003)
Oligosaccharides as receptors for JC virus
R Komagome et al.
JOURNAL OF VIROLOGY (2002)
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS
CM Marra et al.
AIDS (2002)
Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain
Y Okada et al.
ACTA NEUROPATHOLOGICA (2002)
Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA
S Bofill-Mas et al.
JOURNAL OF VIROLOGY (2001)
A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy
WJ Atwood
JOURNAL OF NEUROVIROLOGY (2001)
JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis
MT Pho et al.
JOURNAL OF VIROLOGY (2000)
分享论文
